Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Guam Technology Journal.
Press releases published on August 26, 2025
Aquestive Therapeutics to Participate in Upcoming September Investor Conferences
GlobeNewswire
·
August 26, 2025
WARREN, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and …
Sagimet Biosciences to Participate in Two Upcoming Investor Conferences
GlobeNewswire
·
August 26, 2025
SAN MATEO, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management …
Tango Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference
GlobeNewswire
·
August 26, 2025
BOSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in a fireside chat at the 2025 Cantor …
Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors
GlobeNewswire
·
August 26, 2025
— Aggregate net proceeds from private placement expected to fund SL-325 through multiple Phase 2 clinical trials, including in Inflammatory Bowel Disease (IBD) and potentially another autoimmune disease — — Pro forma cash and cash equivalents, assuming …
Nano Labs CEO Mr. Kong Jianping Increases Shareholdings by 480,000 Shares, Reaffirming Confidence in Long-Term Growth
GlobeNewswire
·
August 26, 2025
HONG KONG, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading Web 3.0 infrastructure and product solution provider, announced that its Chairman and Chief Executive Officer, Mr. Jianping Kong, has …
UCLOUDLINK GROUP INC. to Participate in the 2025 Gateway Conference on September 3-4, 2025
GlobeNewswire
·
August 26, 2025
HONG KONG, Aug. 26, 2025 (GLOBE NEWSWIRE) -- UCLOUDLINK GROUP INC. (“UCLOUDLINK” or the “Company”) (NASDAQ: UCL), the world’s first and leading mobile data traffic sharing marketplace, today announced that it will participate in the 2025 Gateway Conference …
Scenic Enters License and Research Agreement with Alnylam
GlobeNewswire
·
August 26, 2025
Amsterdam, the Netherlands, August 26, 2025 – Scenic Biotech, a pioneer in modifier therapies for severe diseases, today announced a license and research agreement with Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) to leverage Scenic's Cell-Seq platform …
Er-Kim Announces Exclusive Agreement with CNX Therapeutics to Distribute Oncology Products Across CEE and Turkey
GlobeNewswire
·
August 26, 2025
WARSAW, Poland and LONDON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies, today announced a distribution agreement with CNX Therapeutics to supply selected …
Life Biosciences Presents New Data at ARDD 2025 on the Company’s Partial Epigenetic Reprogramming Platform in Liver and Ocular Diseases
GlobeNewswire
·
August 26, 2025
ER-300 improves key biomarkers of liver health in an animal model of MASH These data, along with additional ER-100 preclinical data from a nonhuman primate model of NAION demonstrating clear restoration of methylation patterns with functional enrichment of …
SALT Lending Announces ‘The Bitcoin Advantage’ Book at BTC Asia Amid Record Growth Milestones
GlobeNewswire
·
August 26, 2025
Denver, CO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- SALT Lending, the pioneer in Bitcoin-backed lending and blockchain financial services since 2016, today announced a new book, “The Bitcoin Advantage” at BTC Asia. Written by SALT CRO, Hunter Albright, Phd and …
Osivax Receives $19.5M BARDA Award to Advance Next-Generation Influenza Vaccine for Pandemic and Seasonal Preparedness
GlobeNewswire
·
August 26, 2025
Funding to accelerate development of Osivax’ broad-spectrum influenza A vaccine candidate, OVX836 Lyon, France and Liège, Belgium – August 26, 2025 – Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against …
Rakovina Therapeutics CSO Dr. Mads Daugaard Invited to Present at the 13th Tuscany Retreat on Cancer Research and Apoptosis
GlobeNewswire
·
August 26, 2025
VANCOUVER, British Columbia, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical company advancing cancer therapies through AI-powered drug discovery, today announced that …
CancerVax Achieves Major Milestones and Files Foundational Patent Application
GlobeNewswire
·
August 26, 2025
Lehi, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Lehi, Utah, August 26, 2025 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that uses the body’s immune system to treat cancer, today announced that it recently filed a …
PannTheraPi prepares plans to conduct its first Phase IIa clinical trial with PTI5803 in patients with resistant epilepsy and accelerate the development of its proprietary pipeline
GlobeNewswire
·
August 26, 2025
PannTheraPi prepares plans to conduct its first Phase IIa clinical trial with PTI5803 in patients with resistant epilepsy and accelerate the development of its proprietary pipeline Pre-submission file completed with French regulatory agency (ANSM) to …
PannTheraPi se prépare pour mener son premier essai clinique de phase IIa avec le PTI5803 chez des patients atteints d'épilepsie résistante et accélérer le développement de son portefeuille propriétaire
GlobeNewswire
·
August 26, 2025
PannTheraPi se prépare pour mener son premier essai clinique de phase IIa avec le PTI5803 chez des patients atteints d'épilepsie résistante et accélérer le développement de son portefeuille propriétaire Dossier de pré-soumission finalisé auprès de l'Agence …
PathAI Expands AISight® Dx Primary Diagnosis Clearance to Support VENTANA DP 200 and DP 600 Slide Scanners Through Predetermined Change Control Plan (PCCP)
GlobeNewswire
·
August 26, 2025
BOSTON, Aug. 26, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, today announced the expansion of the AISight® Dx digital pathology image management system 510(k) label (K243391) to include …
Primo TRT Launches Men Health Natural Testosterone Support Supplement
GlobeNewswire
·
August 26, 2025
CHICAGO, ILLINOIS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Primo TRT is a Los Angeles, California-based company that has come up with a dietary supplement called Primo TRT, which is meant to address the health concerns of men. The supplement is intended to help …
Ariceum Therapeutics Appoints David Schilansky as Chief Executive Officer and Announces New Leadership to Advance Next Phase of Development
GlobeNewswire
·
August 26, 2025
David Schilansky transitions to CEO, bringing 25 years of company-building, scaling and financing to advance Ariceum’s pipeline of novel radiotherapeutics Initiation of Phase 1/2 SANTANA-225 study of 225Ac-SSO110 in Extensive stage small cell lung cancer ( …
Nicox annonce la mise en ligne d’une page « Questions-Réponses » sur son site internet
GlobeNewswire
·
August 26, 2025
Communiqué de presse Nicox annonce la mise en ligne d’une page « Questions-Réponses » sur son site internet 26 août 2025 – publication à 7H30 Sophia Antipolis, France Nicox SA (Euronext Growth Paris : FR0013018124, ALCOX, éligible PEA-PME), une société …
Nicox Announces Shareholder Q&A Webpage Available
GlobeNewswire
·
August 26, 2025
Press Release Nicox Announces Shareholder Q…